DESCRIBE <http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E	http://www.w3.org/2000/01/rdf-schema#comment	"meta-analysis indicates that U2AF1 mutants are independent detrimental prognostic factors for overall survival (OS) and acute myeloid leukemia transformation in patients with de novo MDS as well as associating with shorter OS in subgroups of low- or intermediate-1-IPSS U2AF1(S34) and U2AF1(Q157/R156)."xsd:string
http://purl.uniprot.org/uniprot/#_9C71302EFB43A24BD17A6052ABDDB5F53BC61B0DC72A9F88ED41ED6B6536D7D9B12D437E32DD2AC8B8ACFD743212372D	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E
http://purl.uniprot.org/uniprot/B5BU08	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E
http://purl.uniprot.org/uniprot/#_B5BU08-mappedCitation-31754743	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/D956D6BE30A7634ACD737DD83C62BCF65F80D869CD4BE37043DFE94D97FA040EC9753EF57AE8D43ABCDEDC60DED9C21E